Devika Umashanker, M.D., a bariatric medicine physician with Hartford HealthCare Medical & Surgical Weight Loss in Glastonbury, Connecticut
Anyone with metabolic, cardiac, GI, hepatic, or renal disease or who is pregnant, breastfeeding, or planning pregnancy should not consider it without licensed clinical care
94% reduction in progression from pre diabetes to type 2 diabetes with tirzepatide.** **Based on a three-year clinical trial study (176-week treatment period) sponsored by Eli Lilly and Company, weekly injections of tirzepatide significantly reduced the risk of progression to type 2 diabetes by 94% in adults with prediabetes who were overweight or obese compared to placebo
Some women experience insomnia initially , but this typically resolves within the first few weeks
They make me feel like family